Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-7 of 7 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES)

    Rochester, MN

  2. A Study to Evaluate the Effectiveness and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES)

    Rochester, MN

  3. "Prescribing" Exercise to Cancer Patients at High-Risk for Falls

    Rochester, MN

  4. Study in Pediatrics with HypEREosinophilic Syndrome

    Rochester, MN

  5. Mayo Clinic Program for the Study of Mast Cell and Eosinophil Disorders Cell and Serum Bank

    Rochester, MN

  6. Evaluation of Immunophenotype Signatures in Hypereosinophilia-Associated Disorders

    Rochester, MN

  7. Prognostic Risk Evaluation for Hypereosinophilic Syndrome (HES) and Idiopathic Hypereosinophilia (IHE) and the Role of Next-generation Sequencing

    Rochester, MN


Mayo Clinic Footer